PROVE-IT TIMI 22
id:
prove-it-timi-22-248-1071548
title:
PROVE-IT TIMI 22
text:
The Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 trial, also known as PROVE-IT TIMI 22, was a randomized, double-blind, clinical trial that recruited 4,162 people admitted within 10 days of an acute coronary event and randomised them to the lipid-lowering drugs pravastatin (40 mg) or atorvastatin (80 mg) and a 10-day course of the antibiotic gatifloxacin or placebo. The participants enrolled at 349 sites across Australia, Europe, and North
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical clinical trial
original url:
https://en.wikipedia.org/wiki/PROVE-IT_TIMI_22
date created:
date modified:
2024-01-19T12:32:12Z
main entity:
{"identifier":"Q96399972","url":"https://www.wikidata.org/entity/Q96399972"}
image:
fields total:
13
integrity:
14